Control of the development of the pulmonary surfactant system in the saltwater crocodile, Crocodylus porosus.
Pulmonary surfactant is a mixture of lipids and proteins that controls the surface tension of the fluid lining the inner lung. Its composition is conserved among the vertebrates. Here we hypothesize that the in ovo administration of glucocorticoids and thyroid hormones during late incubation will accelerate surfactant development in the saltwater crocodile, Crocodylus porosus. We also hypothesize that the increased maturation of the type II cells in response to hormone pretreatment will result in enhanced responsiveness of the cells to surfactant secretagogues. We sampled embryos at days 60, 68, and 75 of incubation and after hatching. We administered dexamethasone (Dex), 3,5,3'-triiodothyronine (T(3)), or a combination of both hormones (Dex + T(3)), 48 and 24 h before each prehatching time point. Lavage analysis indicated that the maturation of the phospholipids (PL) in the lungs of embryonic crocodiles occurs rapidly. Only T(3) and Dex + T(3) increased total PL in lavage at embryonic day 60, but Dex, T(3), and Dex + T(3) increased PL at day 75. The saturation of the PLs was increased by T(3) and Dex + T(3) at day 68. Swimming exercise did not increase the amount or alter the saturation of the surfactant PLs. Pretreatment of embryos with Dex, T(3), or Dex + T(3) changed the secretion profiles of the isolated type II cells. Dex + T(3) increased the response of the cells to agonists at days 60 and 68. Therefore, glucocorticoids and thyroid hormones regulate surfactant maturation in the crocodile.
Sullivan
Lucy C
LC
Department of Environmental Biology, University of Adelaide, Adelaide, South Australia 5005.
Orgeig
Sandra
S
Daniels
Christopher B
CB
D000489:Alligators and Crocodiles / Q000196:embryology / Q000502:physiology*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology; D004625:Embryo, Nonmammalian / Q000502:physiology*; D047108:Embryonic Development; D005347:Fibroblasts; D005938:Glucocorticoids / Q000494:pharmacology; D008168:Lung / Q000166:cytology / Q000254:growth & development* / Q000502:physiology*; D008854:Microscopy, Electron; D009929:Organ Size / Q000187:drug effects; D010743:Phospholipids / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000254:growth & development / Q000502:physiology; D011663:Pulmonary Surfactants / Q000819:agonists / Q000378:metabolism*; D012623:Seawater; D013550:Swimming / Q000502:physiology; D007507:Therapeutic Irrigation; D014284:Triiodothyronine / Q000494:pharmacology
D005938:Glucocorticoids; D010743:Phospholipids; D011663:Pulmonary Surfactants; D014284:Triiodothyronine; D003907:Dexamethasone